secwatch.observer — SEC 8-K summary
======================================

Issuer:     HUMANIGEN, INC (—)
CIK:        0001293310
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001214659-23-009927
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humanigen to be delisted from Nasdaq July 26; warns of going concern, potential bankruptcy
--------------------------------------------------------------------------------

- Nasdaq will suspend trading July 26, 2023; shares will move to OTC Pink Market.
- Three directors resigned July 18-19 (Hohneker, Buxton, Xie) causing non-compliance with Nasdaq independence rules.
- Business combination negotiations with private biopharma ended; no alternative financing obtained.
- Company states it will not be able to continue as going concern; exploring restructuring including bankruptcy in Q3 2023.
- Any bankruptcy may result in complete or substantial loss of value for common stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293310/000121465923009927/0001214659-23-009927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293310/000121465923009927/j7242308k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-009927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer